Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Appoints Benson Tsang as CFO

August 23, 2006 - Shanghai, China - WuXi PharmaTech recently announced the appointment of Benson Tsang as the Company's chief financial officer.

Mr. Tsang brings over 18 years of finance, public accounting and capital market experience to WuXi PharmaTech from both the public and private sectors. In his most recent position, Mr. Tsang served as China CFO at Pacific Century CyberWorks (PCCW. SEHK: 0008, NYSE: PCW), the largest and most comprehensive provider of communications services in Hong Kong and one of Asia's leading players in Information and Communications Technologies. Mr. Tsang also held a variety of progressive financial and managerial positions in international accounting firms, multinational corporations, and Hong Kong & Singapore listed companies.

"I am very delighted to welcome Benson on board in this exciting time for the company. Benson has valuable strategic, management and financial leadership experience and will be an important part of our executive team as our business continues to grow. "said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech, "His depth of experience in management will surely help the company to become an internationally respected, fully integrated drug R&D service company."

Mr. Tsang is a member of both the Canadian Institute of Chartered Accountants as well as the Hong Kong Institute of Certified Public Accountants. Mr. Tsang earned both his MBA degree and Bachelor of Commerce from McMaster University of Canada.

About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.

back to top